共 148 条
[1]
Burge R(2007)Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025 J Bone Miner Res 22 465-475
[2]
Dawson-Hughes B(2007)Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis New Engl J Med. 356 1809-1822
[3]
Black DM(2013)Osteoporosis in the European Union: medical management, epidemiology and economic burden Arch Osteoporos 8 136-1141
[4]
Delmas PD(1994)The diagnosis of osteoporosis J Bone Min Res 9 1137-1112
[5]
Hernlund E(2004)BMD thresholds for pharmacological intervention to prevent fractures Arch Intern Med 164 1108-1409
[6]
Svedbom A(2006)The population burden of fractures originates in women with osteopenia, not osteoporosis Osteoporos Int 17 1404-1015
[7]
Ivergard M(1961)The pathogenesis of osteoporosis Lancet 1 1011-126
[8]
Kanis JA(1993)Predicting vertebral fracture incidence from prevalent fractures and BMD among non-black, osteoporotic women Osteo Int 3 120-S413
[9]
Melton LJ(2010)Development and use of FRAX in osteoporosis Osteoporos Int 21 S407-125S
[10]
Christiansen C(1996)Epidemiology of hip fractures: implications of the exponential increase with age Bone 18 121S-335